Abstract
Intravesical instillation therapy of bacillus Calmette-Guérin (BCG) is a useful modality for recurrent superficial transitional-cell carcinoma (TCC) of the urinary bladder. The mechanism of BCG effect has not yet been well characterized. BCG was tested in vitro for cytokine-mediated antiproliferative activity against T24 and KK47 cells (cell lines established from human TCC of the urinary bladder), and ACHN cells (cell line established from human renal cell carcinoma) using a modified human tumor clonogenic assay. Continuous exposure of cells to BCG at concentrations of more than 5 μg/ml in the presence of peripheral blood mononuclear cells (PBMC) consisting of a mixture of 5×104 monocytes/dish and 5×105 lymphocytes/dish, obtained from healthy donors, significantly inhibited colony formation of T24 and ACHN cells in comparison with growth inhibition in the absence of PBMC (P<0.05). Slightly inhibited colony formation was observed with KK47 cells under the same conditions. At the same time various cytokines were measured in supernatants when BCG and the same conditioned PBMC were co-cultured. Tumor necrosis factor α (TNFα) and interleukin-1β (IL-1β) were detected at markedly high levels at 24 h, and interferon γ (IFNγ) was detected at 120 h. IL-2 and macrophage-colony-stimulating factor were not detected. Neutralizing anti-TNFα monoclonal antibody significantly reduced the anti-proliferative activity of ACHN cells, and anti-IFNγ antibody reduced that of T24 cells. The results obtained suggest that cytokines mediated by BCG play an important role in the antitumor activity of BCG and that the sensitivity of bladder cancer cells to the cytokines induced by BCG may differ considerably.
Key words: BCG, Cytokine, Human tumor clonogenic assay
References
- 1.Amano T, Kumini K, Nakashima K, Uchibayashi T, Hisazumi H. A combined therapy of hyperthemia and tumor necrosis factor for nude mice brearing KK47 bladder cancer. J Urol. 1990;144:370. doi: 10.1016/s0022-5347(17)39463-6. [DOI] [PubMed] [Google Scholar]
- 2.Bohle A, Gerdes J, Ulmer AJ, Hofstetter AG, Flad HD. Effect of local bacillus Calmette-Guérin therapy in patients with bladder carcinoma on immunocompetent cells of the bladder wall. J Urol. 1990;144:53. doi: 10.1016/s0022-5347(17)39365-5. [DOI] [PubMed] [Google Scholar]
- 3.Bohle A, Nowe CH, Ulmer AJ, Musehold J, Hofstetter AG, Flad HD. Elevations of cytokines interleukin-1, interleukin-2 and tumor necrosis factor in the urine of patients after intravesical bacillus calmette-guerin immunotherapy. J Urol. 1990;144:59. doi: 10.1016/s0022-5347(17)39366-7. [DOI] [PubMed] [Google Scholar]
- 4.De Boer EC, De Jong WH, Van der Meijden APM, Steerenberg PA, Witjes F, Vegt PDJ, Debruyne FMJ, Ruitenberg EJ. Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res. 1991;19:45. doi: 10.1007/BF00294021. [DOI] [PubMed] [Google Scholar]
- 5.De Boer EC, De Jong WH, Steerenberg PA, Aarden LA, Tetteroo E, De Groot ER, Van der Meijden APM, Vegt PDJ, Debruyne FMJ, Ruitenberg EJ. Induction of urinary interleukin-1 (IL-1), IL-2, IL-6 and tumor necrosis factor during intravesical immunotherapy with bacillus Calmette-Guérin in superficial bladder cancer. Cancer Immunol Immunother. 1992;34:306. doi: 10.1007/BF01741551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.El-demiry MIM, Smith G, Ritchie AWS, James K, Cumming JA, hargreave TB, Chisholm GD. Local immune responses after intravesical BCG treatment for carcinoma in situ. Br J Urol. 1987;60:543. doi: 10.1111/j.1464-410x.1987.tb05039.x. [DOI] [PubMed] [Google Scholar]
- 7.Farrar JJ, Benjamin WR, Hilfiker ML, Howard M, Farrar WL, Fuller-Farrar J. The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell response. Immunol Rev. 1982;63:129. doi: 10.1111/j.1600-065x.1982.tb00414.x. [DOI] [PubMed] [Google Scholar]
- 8.Hamburger AW, Salmon SE. Primary bioassay of human stem cells. Science. 1977;197:461. doi: 10.1126/science.560061. [DOI] [PubMed] [Google Scholar]
- 9.Herr HW, Badalament RA, Amato DA, Laudone VP, Fair WA, Whitmore FW., Jr Superficial bladder cancer treated with bacillus calmette-guerin: a multivariate analysis of factors affecting tumor progression. J Urol. 1989;141:22. doi: 10.1016/s0022-5347(17)40575-1. [DOI] [PubMed] [Google Scholar]
- 10.Kavoussi LR, Torrence RJ, Gillen DP, Hudson MA, Haaff EO, Dresner SM, Ratliff TL, Catalona WJ. Results of weekly intravesical bacillus Calmette-Guérin instillations on the treatment of superficial bladder tumors. J Urol. 1988;139:935. doi: 10.1016/s0022-5347(17)42722-4. [DOI] [PubMed] [Google Scholar]
- 11.Leong AS-Y, Wannakrairot P, Jose J, Milios J. Bacillus Calmette-Guérin treated superficial bladder cancer: correlation of morphology with immunophenotyping. J Pathol. 1990;162:35. doi: 10.1002/path.1711620108. [DOI] [PubMed] [Google Scholar]
- 12.Matsuvama H, Yoshihiro S, Ohmoto Y, Yamamoto N, Naito K. Direct and indirect effects of human interferon α on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects. Cancer Immunol Immunother. 1993;37:84–88. doi: 10.1007/BF01517039. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Morales A, Eidinger D, Bruce AW. Intracavitary BCG in the treatment of superficial bladder tumors. J Urol. 1976;116:180. doi: 10.1016/s0022-5347(17)58737-6. [DOI] [PubMed] [Google Scholar]
- 14.Onozaki K, Matsushima K, Kleinerman ES, Saito T, Oppenheim JJ. Role of interleukin 1 in promoting human monocytemediated tumor cytotoxicity. J Immunol. 1985;135:314. [PubMed] [Google Scholar]
- 15.Pansandoro V, Paula F. Intravesical bacillus Calmette-Guérin in the treatment of superficial transitional cell carcinoma of the bladder. J Urol. 1987;138:299. doi: 10.1016/s0022-5347(17)43127-2. [DOI] [PubMed] [Google Scholar]
- 16.Prescott S, James K, Hargreave TB, Chisholm GD, Smyth JF. Radioimmunoassay detection of interferon-gamma in urine after intravesical evans BCG therapy. J Urol. 1990;144:1248. doi: 10.1016/s0022-5347(17)39713-6. [DOI] [PubMed] [Google Scholar]
- 17.Rajala P, Kaasinen E, Rintala E, Jauhiainen K, Nurmi M, Alfthan O, Lahde M. Cytostatic effect of different strains of bacillus Calmette-Guerin on human bladder cancer cells in vitro alone and in combination with mitomycin C and interferon-α. Urol Res. 1992;20:215. doi: 10.1007/BF00299720. [DOI] [PubMed] [Google Scholar]
- 18.Rattiff TL, Gillen D, Catalona WJ. Requirement of a thymus dependent immune response for BCG-mediated antitumor activity. J Urol. 1987;137:155. doi: 10.1016/s0022-5347(17)43909-7. [DOI] [PubMed] [Google Scholar]
- 19.Schamhart DHJ, Kurth KH, de Reijke TM, Vleeming R. BCG treatment and the importance of an inflammatory response. Urol Res. 1992;20:199. doi: 10.1007/BF00299717. [DOI] [PubMed] [Google Scholar]
- 20.Smith KA, Lachman LB, Oppenheim JJ, Favata MF. The functional relationship of the interleukins. J Exp Med. 1980;151:1551. doi: 10.1084/jem.151.6.1551. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Sugarman BJ, Aggarwal BB, Hass PE, Figari IS, Palladino MA, Jr, Shepard HM. Recombinant human tumor necrosis factor-α: effect on proliferation of normal and transformed cells in vitro. Science. 1985;230:943. doi: 10.1126/science.3933111. [DOI] [PubMed] [Google Scholar]
- 22.Tanaka K, Ishikawa E, Ohmoto Y, Hirai Y. In vitro production of human interleukin 1α and interleukin 1 β by peripheral blood mononuclear cells examined by sensitive sandwich enzyme immunoassay. Eur J Immunol. 1987;17:1527. doi: 10.1002/eji.1830171024. [DOI] [PubMed] [Google Scholar]
- 23.Valone SE, Rich EA, Wallis RS, Ellner JJ. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with wholeMycobacterium bovis BCG and mycobacterial antigens. Infect Immun. 1988;56:3313. doi: 10.1128/iai.56.12.3313-3315.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]